(-)-Licarin B
CAS No. 51020-87-2
(-)-Licarin B ( Licarin B )
Catalog No. M18686 CAS No. 51020-87-2
1.(-)-Licarin B has anti-mycobacterial activity.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 63 | In Stock |
|
10MG | 99 | In Stock |
|
25MG | 164 | In Stock |
|
50MG | 244 | In Stock |
|
100MG | 365 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(-)-Licarin B
-
NoteResearch use only, not for human use.
-
Brief Description1.(-)-Licarin B has anti-mycobacterial activity.
-
DescriptionLicarin B is a neolignan isolated from seeds of Myristica fragrans.
-
SynonymsLicarin B
-
PathwayOthers
-
TargetOther Targets
-
Recptoranti-mycobacterial
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number51020-87-2
-
Formula Weight324.37
-
Molecular FormulaC20H20O4
-
Purity98%
-
Solubility——
-
SMILESCC=CC1=CC2=C(C(=C1)OC)OC(C2C)C3=CC4=C(C=C3)OCO4
-
Chemical Name5-((2R,3R)-7-methoxy-3-methyl-5-((E)-prop-1-en-1-yl)-2,3-dihydrobenzofuran-2-yl)benzo[d][1,3]dioxole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Citreorosein
Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.
-
MEISi-2
MEISi-2 is a potent MEIS inhibitor (MEISi). MEISi-2 significantly inhibits MEIS-luciferase reporters in vitro.
-
Byakangelicin
Byakangelicin is an antineoplastic agent.